Exagen Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Exagen Inc. (XGN) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents22.0436.4962.3999.4457.4572.08
Cash & Short-Term Investments22.0436.4962.3999.4457.4572.08
Accounts Receivable7.846.556.109.658.915.72
Inventory0.002.871.801.091.200.00
Other Current Assets0.861.931.801.091.201.43
Total Current Assets36.4647.8472.61112.7370.5281.25
Non-Current Assets
Property, Plant & Equipment (Net)7.688.4913.084.772.101.38
Goodwill0.000.000.005.515.510.00
Other Non-Current Assets0.550.620.530.430.250.17
Total Non-Current Assets8.239.1013.6110.717.867.06
Total Assets44.6956.9486.22123.4578.3888.31
Current Liabilities
Accounts Payable4.143.138.399.328.775.90
Short-Term Debt0.420.260.190.000.000.00
Current Portion of Long-Term Debt0.420.260.190.000.000.00
Accrued Liabilities7.857.044.206.245.450.00
Other Current Liabilities7.850.308.006.004.100.00
Total Current Liabilities13.5111.909.629.328.775.90
Non-Current Liabilities
Long-Term Debt19.8219.2333.2727.4826.6625.85
Deferred Tax Liabilities0.000.000.000.310.160.00
Other Non-Current Liabilities0.160.360.871.410.950.64
Total Non-Current Liabilities21.6422.3534.1429.1927.7726.76
Total Liabilities35.1534.2543.7638.5136.5432.65
Stockholders' Equity
Common Stock0.020.020.020.020.010.00
Retained Earnings-294.33-279.22-255.53-208.14-181.29-164.60
Additional Paid-in Capital303.85301.89297.97293.06223.12220.25
Shares Outstanding17.6417.0516.5516.160.000.00
Total Stockholders' Equity9.5422.6942.4684.9441.8455.66
Total Liabilities & Equity44.6956.9486.22123.4578.3888.31